Biochemical properties of OR-1259--a positive inotropic and vasodilatory compound with an antiarrhythmic effect.
Raasmaja
A
A
Orion Pharmaceutica, Espoo, Finland.
Talo
A
A
Haikala
H
H
Nissinen
E
E
Lindén
I B
IB
Pohto
P
P
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism; D002316:Cardiotonic Agents / Q000494:pharmacology*; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006835:Hydrazones / Q000494:pharmacology*; D066298:In Vitro Techniques; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D011724:Pyridazines / Q000494:pharmacology*; D012508:Sarcolemma / Q000187:drug effects / Q000378:metabolism; D000077464:Simendan; D014665:Vasodilator Agents / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D006835:Hydrazones; D010726:Phosphodiesterase Inhibitors; D011724:Pyridazines; D014665:Vasodilator Agents; D000077464:Simendan; D002118:Calcium